Molina Healthcare Inc (MOH)
🔔 Watch stock
Stock Watch
Stock Watch will tell you what changes at Molina Healthcare Inc.
Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.
Appears in These Scanners
This stock currently matches 12 of our scanner strategies — each hit links to the scanner.
Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. View all scanners
Trading Day
Key levels of the most recently completed trading day — not a live quote.
52-Week Range
Current price 195.60 $ — 61% of the range above the low.
Lowest and highest closing price over the last 52 weeks. The marker shows where the current price sits within that range: close to the high speaks for strength, close to the low for weakness.
Basics
Performance
Technical Indicators
Calculated from the price history · as of 08/03/2026
Valuation
Profitability
Balance Sheet & Safety
Growth
Dividend
This stock currently pays no dividend.
Quality & Screener
AI Rating
–Not yet rated — we only show a category once an SEC-backed file with at least two cited passages is available. How the Rating Is Built
Growth Score
2 of 10 Weak growthTen checks against the annual reports — each one passed counts a point.
- Revenue grows by more than 15% a year over three years 12.4% failed
- More than 10% revenue growth is expected for the coming year 7.0% failed
- Share count grows by less than 3% a year -4.6% passed
- Revenue growth plus cash-flow margin add up to at least 40 ("Rule of 40") 10.4% failed
- Gross margin at 40% or higher and without meaningful erosion 13.1% failed
- Goodwill from acquisitions does not grow faster than revenue 12.6% failed
- Net debt below twice EBITDA 4,306 m net cash passed
- Operating cash flow covers the profits of the last three years -971 m failed
- Return on capital at 15% or higher, or up versus two years ago 9.5% failed
- Insiders hold at least 10% or are net buyers 1.4% failed
A criterion without figures counts neither as passed nor as failed; a score is only produced from 7 judgeable criteria upwards. Source: fundamental data. All ten criteria in detail
Highlighted are things our editorial team noticed: green = stands out as strong, red = deserves a closer look. No single metric is a verdict on its own — always read it in context.
Analysts & Price Target
The price target sits 6.9% above the current price.
- Consensus
- Sell
- Analyst Ratings
- 16
Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.
Estimates by Fiscal Year
| Fiscal Year | EPS Estimate ($) | EPS Range ($) | Revenue Estimate ($M) | Expected Growth | Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 5.24 | 4.85 – 5.50 | 44,435 | -52.5% | 19 |
| 12/31/2027 | 8.55 | 3.31 – 10.29 | 48,082 | 85.8% | 6 |
Average of the analyst estimates for the coming fiscal years. The range shows how far the most optimistic and the most cautious estimate sit apart — the wider it is, the less certain the expectation.
Next Reporting Date
- Expected Earnings per Share
- 0.82 $
Expected date of the next quarterly or annual figures. Dates do shift occasionally — only the invitation issued by the company is binding.
Revenue & Profit
Cash Flow
Balance Sheet
Margins
Per Share
Click the chart or tab into it, then use ← and → to step through the periods.
None of the selected stocks reports this metric. Pick another metric or switch between annual and quarterly.
· Total · per year
These companies report in different currencies — switch on “Indexed” or pick a margin for a fair comparison.
The figures could not be loaded right now.
Source: fundamental data
Quarterly Figures
| Quarter | EPS (Earnings Per Share) | EPS YoY (%) | Sales ($M) | Sales YoY (%) | Net Margin (%) | OCF ($M) | FCF ($M) |
|---|---|---|---|---|---|---|---|
| 2024: Q4 | 4.35 | 17.20 | 10,499 | 16.00 | 2.40 | -224 | -235 |
| 2025: Q1 | 5.44 | 5.30 | 11,147 | 12.20 | 2.70 | 190 | 168 |
| 2025: Q2 | 4.70 | -9.20 | 11,427 | 15.70 | 2.20 | -302 | -344 |
| 2025: Q3 | 1.47 | -73.90 | 11,477 | 11.00 | 0.70 | -125 | -163 |
| 2025: Q4 | -3.15 | -172.40 | 11,375 | 8.30 | -1.40 | -298 | -297 |
| 2026: Q1 | 0.27 | -95.00 | 10,796 | -3.10 | 0.10 | 1,082 | 1,055 |
| 2026: Q2 | 1.19 | -74.70 | 10,874 | -4.80 | 0.60 | -294 | -324 |
- EPS (Earnings Per Share):
- Quarterly profit divided by the total share count — how much of the profit works out to a single share.
- YoY (Year over Year):
- Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
- Sales:
- All revenue for the quarter, before any costs are deducted — the top line of the income statement.
- Net Margin:
- What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
- OCF (Operating Cash Flow):
- The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
- FCF (Free Cash Flow):
- Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.
Annual Figures
| Fiscal Year | Revenue ($M) | EBIT ($M) | Net Income ($M) | EPS ($) | Operating Cash Flow ($M) | Equity ($M) | Total Assets ($M) |
|---|---|---|---|---|---|---|---|
| 2016 | 17,711 | 306 | 8 | 0.14 | 673 | 1,649 | 7,449 |
| 2017 | 19,883 | -555 | -512 | -9.14 | 804 | 1,337 | 8,471 |
| 2018 | 18,890 | 1,131 | 707 | 10.55 | -314 | 1,647 | 7,154 |
| 2019 | 16,829 | 1,044 | 737 | 11.48 | 427 | 1,960 | 6,787 |
| 2020 | 19,423 | 1,078 | 673 | 11.24 | 1,890 | 2,096 | 9,532 |
| 2021 | 27,771 | 1,020 | 659 | 11.25 | 2,119 | 2,630 | 12,209 |
| 2022 | 31,974 | 1,381 | 792 | 13.54 | 773 | 2,964 | 12,314 |
| 2023 | 34,072 | 1,573 | 1,091 | 18.78 | 1,662 | 4,215 | 14,892 |
| 2024 | 40,650 | 1,707 | 1,179 | 20.43 | 644 | 4,496 | 15,630 |
| 2025 | 45,426 | 781 | 472 | 9.29 | -535 | 4,069 | 15,564 |
Fiscal years from the audited annual reports, oldest first. EBIT is the operating profit before interest and taxes; total assets are everything the company owns.
About the Company
Molina Healthcare, Inc. bietet Managed-Healthcare-Dienste für einkommensschwache Familien und Privatpersonen im Rahmen der Medicaid- und Medicare-Programme sowie über die staatlichen Versicherungsmarktplätze in den USA an.
| Employees | 19,000 |
|---|---|
| Headquarters | Long Beach, CA |
| Address | 200 Oceangate, 90802 Long Beach, United States |
| Phone | (562) 435-3666 |
| Website | molinahealthcare.com |
| IPO Date | 2. Jul 2003 |
| ISIN | US60855R1005 |
| Stock Split | 3:2 on 05/23/2011 |
Management
| Name | Title | Birth Year |
|---|---|---|
| Joseph Michael Zubretsky | President, CEO & Director | 1957 |
| Mark Lowell Keim | Senior EVP, CFO & Treasurer | 1965 |
| James Edwin Woys | Senior EVP & COO | 1959 |
| Jeffrey Don Barlow Esq., J.D., M.P.H. | Chief Legal Officer & Corporate Secretary | 1963 |
| Debra Jean Bacon | Executive Vice President of Medicaid | 1967 |
| Maurice Sebastian Hebert CPA | Chief Accounting Officer | 1963 |
| Jeffrey Geyer | Head of Investor Relations | – |
| Joann Zarza-Garrido | Vice President of Compliance | – |
| Larry D. Anderson | Executive VP & Chief Human Resources Officer | – |
| Keith Wilson M.D. | Chief Medical Officer | – |
Executives per the latest required filings; titles kept in their original language. Source: fundamental data.
Chart
Interactive price chart (TradingView).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.